Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

Why is Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 3.19%

The company has been able to generate a Return on Capital Employed (avg) of 3.19% signifying low profitability per unit of total capital (equity and debt)

Poor long term growth as Net Sales has grown by an annual rate of 0.52% and Operating profit at 22.43% over the last 5 years

Negative results in Sep 25

OPERATING CASH FLOW(Y) Lowest at CNY 186.07 MM
RAW MATERIAL COST(Y) Grown by 7.22% (YoY)
INVENTORY TURNOVER RATIO(HY) Lowest at 4.62 times

With ROE of 2.67%, it has a very attractive valuation with a 1.41 Price to Book Value

Over the past year, while the stock has generated a return of -4.17%, its profits have fallen by -0.2%
At the current price, the company has a high dividend yield of 2.2

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -4.17% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

-100.0%

0.36

25.64%

China Shanghai Composite

8.25%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-1.35%

EBIT Growth (5y)

19.07%

EBIT to Interest (avg)

5.91

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.25

Sales to Capital Employed (avg)

0.80

Tax Ratio

48.66%

Dividend Payout Ratio

97.77%

Pledged Shares

Institutional Holding

ROCE (avg)

3.98%

ROE (avg)

1.97%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.99

EV to EBIT

25.09

EV to EBITDA

12.57

EV to Capital Employed

0.98

EV to Sales

0.88

PEG Ratio

Dividend Yield

1.46%

ROCE (Latest)

3.92%

ROE (Latest)

1.52%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

RAW MATERIAL COST(Y)

Fallen by 0.88% (YoY

-16What is not working for the Company

NET PROFIT(HY)

At CNY -0.61 MM has Grown at -102.29%

ROCE(HY)

Lowest at 1.54%

INVENTORY TURNOVER RATIO(HY)

Lowest at 4.55 times

NET SALES(Q)

Lowest at CNY 422.94 MM

OPERATING PROFIT(Q)

Lowest at CNY 20.42 MM

Here's what is working for Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

Raw Material Cost

Fallen by 0.88% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

Net Profit

At CNY -0.61 MM has Grown at -102.29%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Net Sales

At CNY 422.94 MM has Fallen at -13.35%

over average net sales of the previous four periods of CNY 488.09 MM

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Inventory Turnover Ratio

Lowest at 4.55 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Net Sales

Lowest at CNY 422.94 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 20.42 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)